Product Information

HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.1382 per EA under NDC 64380044101. Its NADAC has been published 46 times since Oct 8, 2025.

FDA first approved this application on Jun 15, 2016. Its Orange Book therapeutic-equivalence code is AA.

HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET

hydrocodone bitartrate and acetaminophen
$0.1382per EA
DEA Schedule CII

Strength

325; 7.5 mg/1; mg/1

NDC

64380044101

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA202935

FDA Approved

6/15/2016

TE Code

AA

On Market Since

9/1/2025

Pharmacological Classes

Opioid Agonist
Opioid Agonists

Price Statistics

The NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has been published 46 times since Oct 8, 2025, and over the history we have for it it has declined 9.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1382 per EA
All-time high$0.1522 (Oct 15, 2025)
All-time low$0.1379 (Apr 22, 2026)
52-week high$0.1522
52-week low$0.1379
Median price$0.1397
Average price$0.1419
Largest weekly change-4.2% (Dec 17, 2025)
Weeks tracked46
Tracking sinceOct 8, 2025

Price History

1W

-0.5%

1M

-0.5%

3M

+0.1%

6M

-0.3%

1Y

N/A

3Y

N/A

5Y

N/A

All

-9.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the hydrocodone bitartrate and acetaminophen market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET, manufactured by Strides Pharma Inc., is $0.1382 per EA (NDC 64380044101), effective Aug 19, 2026.

How has the price of HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET changed over time?

Over the history we have for it, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has declined 9.2%. It has been tracked across 46 weekly CMS publications since Oct 8, 2025.

What are the highest and lowest recorded NADAC prices for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

Since Oct 8, 2025, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has ranged from a low of $0.1379 (Apr 22, 2026) to a high of $0.1522 (Oct 15, 2025), with a median of $0.1397 per EA.

Are there cheaper alternatives to HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET (NDC 64380044101) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.